Current Approaches to the Surgical Management of GERD
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
4/13/2019: 12:00 AM
Ends On:
6/30/2019: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.5
Description:
Associate Professor, Surgery
Division of General Surgery
Section of Minimally Invasive Surgery
Disclosures
Financial Relationships - Ownership/Stock Equity: Thumbroll
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 27th Annual Refresher Course & Update in General Surgery, February 28 - March 2, 2019, which was supported in part by Barnes-Jewish Hospital, Davol/CR Bard, Olympus Corporation of the Americas, Ethicon USA, and Genomic Health Inc.
Financial Relationships
Consulting/ Advisory Committees: Bard Davol, Medtronic, Colorado Therapeutics, Intuitive Surgical
Research Support/Grant: Medtronic, Colorado Therapeutics
Speakers' Bureaus/Honoraria: Intuitive Surgical, Bard Davol, Cook Medical
Maria B. Majella Doyle, MD, Associate Professor of Surgery, (Co-Chair)
Financial Relationships
Consulting/Advisory Committees: Novartis
Peggy Frisella, RN, BSN, Manager of Research Operations, Section of Minimally Invasive Surgery
Financial Relationships: Speaker has nothing to disclose
Steven R. Hunt, MD, Associate Professor of Surgery, Director, Colon & Rectal Surgery Fellowship Program (Co-Chair)
Financial Relationships: Speaker has nothing to disclose
Faculty
Michael M. Awad, MD, PhDAssociate Professor, Surgery
Division of General Surgery
Section of Minimally Invasive Surgery
Disclosures
Financial Relationships - Ownership/Stock Equity: Thumbroll
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, 27th Annual Refresher Course & Update in General Surgery, February 28 - March 2, 2019, which was supported in part by Barnes-Jewish Hospital, Davol/CR Bard, Olympus Corporation of the Americas, Ethicon USA, and Genomic Health Inc.
Planning Committee
Jeffrey A. Blatnik, MD, Assistant Professor of SurgeryFinancial Relationships
Consulting/ Advisory Committees: Bard Davol, Medtronic, Colorado Therapeutics, Intuitive Surgical
Research Support/Grant: Medtronic, Colorado Therapeutics
Speakers' Bureaus/Honoraria: Intuitive Surgical, Bard Davol, Cook Medical
Maria B. Majella Doyle, MD, Associate Professor of Surgery, (Co-Chair)
Financial Relationships
Consulting/Advisory Committees: Novartis
Peggy Frisella, RN, BSN, Manager of Research Operations, Section of Minimally Invasive Surgery
Financial Relationships: Speaker has nothing to disclose
Steven R. Hunt, MD, Associate Professor of Surgery, Director, Colon & Rectal Surgery Fellowship Program (Co-Chair)
Financial Relationships: Speaker has nothing to disclose
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Describe the role of surgery for treatment of GERD
- List the necessary components of the anti-reflux surgery pre-operative workup
- Be familiar with new therapies for the treatment of GERD
Additional Information:
Target Audience: This course is designed for General and Specialty Surgeons, non-surgical physicians, and medical professionals interested in the following surgical areas: colorectal, endocrine, breast, hernia, minimally invasive, hepatobiliary, surgical oncology, and trauma and critical care surgery.
Publication Date: April 13, 2019
Expiration Date: June 30, 2019
Target Audience: This course is designed for General and Specialty Surgeons, non-surgical physicians, and medical professionals interested in the following surgical areas: colorectal, endocrine, breast, hernia, minimally invasive, hepatobiliary, surgical oncology, and trauma and critical care surgery.
Publication Date: April 13, 2019
Expiration Date: June 30, 2019
Accreditation Information:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
- Frank L et al. Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci. 2000;45:809–818
- Gastroenterology. 2002;122:1500–1511
- Spechler SJ, NEJM, 326:786-92
- Surg Endo 2002, 15:986-989
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
